Skip to main content

Advertisement

Table 3 Cox Proportional Hazards Univariate Analysis (N = 158 unless otherwise noted). 95% confidence levels are indicated in the parentheses for the Hazard Ratios (HR)

From: Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer

Characteristic HR OS P OS HR PFS P PFS
Clinical Stage 2.0 (1.1–3.4) 0.02 2.1 (1.4–3.3) < 0.001
Grade 1 1.0 1.1 (0.5–2.3) 0.77
Age 1.08 (1.05–1.1) < 0.001 1.05 (1.0–1.1) < 0.001
Lymph Node Status (N = 120) 2.5 (1.4–4.5) 0.002 2.7 (1.6–4.4) < 0.001
PR status 1.1 (0.4–3.1) 0.83 1.1 (0.5–2.7) 0.76
Stroma 1.1 (0.6–2.3) 0.73 1.1 (0.6–2.0) 0.72
TILs 0.96 (0.92–1.0) 0.027 0.97 (0.9–1.0) 0.025
ColXα1 2.3 (1.3–4.1) 0.006 1.8 (1.2–2.8) 0.008